{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:43:20Z","timestamp":1793432600072,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["132168"],"award-info":[{"award-number":["132168"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["137997"],"award-info":[{"award-number":["137997"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmc.2022.117030","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T12:27:02Z","timestamp":1663936022000},"page":"117030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Isatoic anhydrides as novel inhibitors of monoamine oxidase"],"prefix":"10.1016","volume":"73","author":[{"given":"Rialette","family":"Hitge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00e9l","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus P.","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.117030_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-981-10-7757-9_5","article-title":"Monoamine oxidases","volume":"87","author":"Edmondson","year":"2018","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bmc.2022.117030_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","article-title":"Monoamine oxidase: from genes to behavior","volume":"22","author":"Shih","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.bmc.2022.117030_b0015","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-018-1927-8","article-title":"Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy","volume":"125","author":"Shih","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.bmc.2022.117030_b0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmc.2022.117030_b0025","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2022.117030_b0030","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2174\/0929867043364784","article-title":"Structure and mechanism of monoamine oxidase","volume":"11","author":"Edmondson","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0035","first-page":"31","article-title":"On tyramine, food, beverages and the reversible MAO inhibitor moclobemide","volume":"26","author":"Da Prada","year":"1988","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.bmc.2022.117030_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4088\/JCP.11096su1c.03","article-title":"Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update","volume":"73","author":"Flockhart","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bmc.2022.117030_b0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/jcbfm.1983.80","article-title":"Monoamine oxidase activity in brain microvessels determined using natural and artificial substrates: relevance to the blood-brain barrier","volume":"3","author":"Lasbennes","year":"1983","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bmc.2022.117030_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-4159.2004.02501.x","article-title":"Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators","volume":"90","author":"Berry","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2022.117030_b0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00702-017-1709-8","article-title":"Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis","volume":"125","author":"Naoi","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.bmc.2022.117030_b0060","doi-asserted-by":"crossref","unstructured":"Schwartz TL. A neuroscientific update on monoamine oxidase and its inhibitors. CNS Spectr 2013;18 Suppl 1:25-32; quiz 33. 10.1017\/S1092852913000734.","DOI":"10.1017\/S1092852913000734"},{"key":"10.1016\/j.bmc.2022.117030_b0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1092852912000594","article-title":"Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression","volume":"17","author":"Lum","year":"2012","journal-title":"CNS Spectr"},{"key":"10.1016\/j.bmc.2022.117030_b0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1586\/14737175.5.6.811","article-title":"Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors","volume":"5","author":"Henchcliffe","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bmc.2022.117030_b0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0197-4580(97)00037-7","article-title":"Age-related increases in brain monoamine oxidase B in living healthy human subjects","volume":"18","author":"Fowler","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmc.2022.117030_b0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2013.12.032","article-title":"Monoamine oxidases as sources of oxidants in the heart","volume":"73","author":"Kaludercic","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.bmc.2022.117030_b0085","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00702-018-1908-y","article-title":"Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology","volume":"125","author":"Mialet-Perez","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.bmc.2022.117030_b0090","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1016\/j.bmcl.2013.08.071","article-title":"Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives","volume":"23","author":"Meiring","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117030_b0095","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1016\/j.bmc.2011.06.070","article-title":"Inhibition of monoamine oxidase by C5-substituted phthalimide analogues","volume":"19","author":"Manley-King","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bmc.2010.11.028","article-title":"Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues","volume":"19","author":"Manley-King","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0105","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1021\/jm001028o","article-title":"Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs","volume":"43","author":"Gnerre","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0110","doi-asserted-by":"crossref","DOI":"10.1021\/jm3017865","article-title":"Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro","author":"Katane","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0115","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0026-895X(25)09633-6","article-title":"Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes","volume":"36","author":"McBain","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2022.117030_b0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mp.2009.99","article-title":"The neurobiology of D-amino acid oxidase and its involvement in schizophrenia","volume":"15","author":"Verrall","year":"2010","journal-title":"Mol Psychiatr."},{"key":"10.1016\/j.bmc.2022.117030_b0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2004.12.037","article-title":"D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia","volume":"57","author":"Heresco-Levy","year":"2005","journal-title":"Biol Psychiat."},{"key":"10.1016\/j.bmc.2022.117030_b0130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol Psychiat."},{"key":"10.1016\/j.bmc.2022.117030_b0135","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1021\/jm900128w","article-title":"Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors","volume":"52","author":"Duplantier","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0140","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1021\/jm400095b","article-title":"4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors","volume":"56","author":"Hondo","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0145","first-page":"269","article-title":"The nature of D-serine\u2013induced nephrotoxicity","volume":"77","author":"Ganote","year":"1974","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bmc.2022.117030_b0150","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.jchromb.2011.08.030","article-title":"Analysis of free D-serine in mammals and its biological relevance","volume":"879","author":"Nishikawa","year":"2011","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.bmc.2022.117030_b0155","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1021\/tx0500326","article-title":"D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity","volume":"18","author":"Maekawa","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmc.2022.117030_b0160","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease","volume":"45","author":"Sterling","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0165","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ejmech.2017.10.050","article-title":"Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents","volume":"143","author":"Carradori","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0170","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.bmc.2022.117030_b0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00023210-199912040-00005","article-title":"Selectivity of cholinesterase inhibition - Clinical implications for the treatment of Alzheimer's disease","volume":"12","author":"Weinstock","year":"1999","journal-title":"Cns Drugs"},{"key":"10.1016\/j.bmc.2022.117030_b0180","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2022.117030_b0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1041610203008676","article-title":"Butyrylcholinesterase: An important new target in Alzheimer's disease therapy","volume":"14","author":"Greig","year":"2002","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.bmc.2022.117030_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126754","article-title":"Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening","volume":"29","author":"Williams","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117030_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/cn4002126","article-title":"Synthesis, biological evaluation, and computational studies of Tri- and tetracyclic nitrogen-bridgehead compounds as potent dual-acting AChE inhibitors and hH3 receptor antagonists","volume":"5","author":"Darras","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2022.117030_b0200","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0021-9258(18)69497-9","article-title":"A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine","volume":"235","author":"Weissbach","year":"1960","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0205","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cmdc.201500059","article-title":"Indanones as high-potency reversible inhibitors of monoamine oxidase","volume":"10","author":"Mostert","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2022.117030_b0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/abio.1997.2392","article-title":"A one-step fluorometric method for the continuous measurement of monoamine oxidase activity","volume":"253","author":"Zhou","year":"1997","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2022.117030_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105791","article-title":"Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase","volume":"123","author":"Bester","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2022.117030_b0225","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.taap.2013.10.014","article-title":"The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase","volume":"274","author":"Petzer","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bmc.2022.117030_b0230","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1073\/pnas.0710626105","article-title":"Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates\/inhibitors","volume":"105","author":"Son","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2022.117030_b0235","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1021\/jm070677y","article-title":"Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs","volume":"50","author":"Binda","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117030_b0240","unstructured":"DeLano WL. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, USA; 2002."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:20:39Z","timestamp":1760836839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622004230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"alternative-id":["S0968089622004230"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117030","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isatoic anhydrides as novel inhibitors of monoamine oxidase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117030"}}